SCHEMBL8873073

SCHEMBL8873073

O=c1[nH]c2c(Cl)cc(Cl)cc2oc1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 4/20 0.52
GRIN3B O60391 4/20 0.52
GRIN1 Q05586 4/20 0.52
GRIN2A Q12879 4/20 0.52
GRIN2B Q13224 4/20 0.52
GRIN2C Q14957 4/20 0.52
GRIN3A Q8TCU5 4/20 0.52
HSD17B10 Q99714 3/20 0.52
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 2/20 0.52
GAA P10253 1/20 0.52
MAOB P27338 1/20 0.37
KMO O15229 1/20 0.35
AHR P35869 3/20 0.34
LMNA P02545 2/20 0.33
CYP1A2 P05177 2/20 0.33
TSHR P16473 2/20 0.33
THPO P40225 2/20 0.33
BLM P54132 2/20 0.33
HPGD P15428 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10884762 0.81 KMO (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL11125122 0.79 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8873191 0.78 GRIN2D (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8871995 0.70 PSMB8 (0.58) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6407742 0.70 GRIN2D (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8872218 0.69 GRIN2D (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2639494 0.68 GRIN2D (1.00) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8871997 0.67 CYP1A2 (0.68) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8873737 0.67 DAO (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30804569 0.67 HSD17B10 (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597922-A Glycine receptor antagonist pharmacophore STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) 1997-01-28 US disclosed
WO-1996004288-A1 GLYCINE RECEPTOR ANTAGONIST PHARMACOPHORE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1996-02-15 WO disclosed
EP-0028392-B1 PROCESS FOR THE PREPARATION OF 2,3-DIOXO-1,4-BENZOXAZINE DERIVATIVES BASF Aktiengesellschaft (DE) 1983-02-16 EP disclosed
US-4297491-A Preparation of 2,3-dioxo-1,4-benzoxazine derivatives BASF AKTIENGESELLSCHAFT (DE) 1981-10-27 US disclosed
EP-0028392-A1 Process for the preparation of 2,3-dioxo-1,4-benzoxazine derivatives BASF Aktiengesellschaft (DE) 1981-05-13 EP disclosed